Treatment Horizons

Treatment Horizons by Chael Needle Fully Personalized An immunotherapy candidate stimulates T-cell responses via patient-specific antigens Previous studies have established immunotherapy candidate AGS-004, both as a single...

AIDS Healthcare Foundation Trains a Research Lens on Probiotics by Chael Needle "Probiotics” has become a new buzz word in the dairy aisle—at least two brands...

Warts & All An immunotherapy candidate seeks to address complications from HPV by Chael Needle Human papillomavirus (HPV) is the most common sexually transmitted infection, but, according...

Close to the Edit A functional cure candidate modifies genes to create HIV-resistant cells by Chael Needle Gary Blick, MD, AAHIVS, Medical & Research Director of CIRCLE...

Hide and Seek Led by Dr. Daria Hazuda, researchers tackle HIV latency with HDAC inhibitors by Chael Needle With all the talk around viral suppression, it may...

LifeGuide Opening Doors A new survey uncovers barriers to treatment by Chael Needle There’s an old chestnut that goes something like this: People won’t make a change...

A bacterium with a live biotherapeutic grows into a microbicide candidate by Chael Needle LifeGuide The development of female-initiated HIV prevention methods—female condoms, antiretroviral treatment as prevention,...

Nuclear Waste How to get overwhelmed by the data on new nukes, old nukes & lots of different classes of ART at AIDS 2014 by Mariel...

When it comes to Effective HIV reform, don’t throw the baby out with the bathwater by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD LifeGuide Extensive progress in...

A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched by Chael Needle Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...